NDC 42291-753

Tacrolimus

Tacrolimus Capsules

Tacrolimus is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Tacrolimus.

Product ID42291-753_a1366897-9f87-de1c-e053-2a95a90a64ab
NDC42291-753
Product TypeHuman Prescription Drug
Proprietary NameTacrolimus
Generic NameTacrolimus Capsules
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2020-03-19
Marketing CategoryANDA /
Application NumberANDA206651
Labeler NameAvKARE
Substance NameTACROLIMUS
Active Ingredient Strength1 mg/1
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 42291-753-01

100 CAPSULE in 1 BOTTLE (42291-753-01)
Marketing Start Date2020-03-19
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tacrolimus" or generic name "Tacrolimus Capsules"

NDCBrand NameGeneric Name
68992-3010EnvarsusTacrolimus
68992-3040EnvarsusTacrolimus
68992-3075EnvarsusTacrolimus
0469-0607PrografTacrolimus
0469-0617PrografTacrolimus
0469-0657PrografTacrolimus
0469-1230PrografTacrolimus
0469-1330PrografTacrolimus
0469-3016PrografTacrolimus
21695-170PrografTacrolimus
43353-178PrografTacrolimus
0469-5201ProtopicTacrolimus
0469-5202ProtopicTacrolimus
50222-203ProtopicTacrolimus
50222-211ProtopicTacrolimus
0168-0416Tacrolimustacrolimus
0168-0417Tacrolimustacrolimus
0378-2045TacrolimusTacrolimus
0378-2046TacrolimusTacrolimus
0378-2047TacrolimusTacrolimus
0781-2102TacrolimusTacrolimus
0781-2103TacrolimusTacrolimus
0781-2104TacrolimusTacrolimus
0781-9302TacrolimusTacrolimus
0781-9303TacrolimusTacrolimus
0781-9304TacrolimusTacrolimus
0904-6425TacrolimusTacrolimus
0904-6623TacrolimusTacrolimus
0904-6624TacrolimusTacrolimus
16729-041TacrolimusTacrolimus
16729-042TacrolimusTacrolimus
16729-043TacrolimusTacrolimus
43353-317TacrolimusTacrolimus
43817-421TacrolimusTacrolimus
43817-422TacrolimusTacrolimus
43817-423TacrolimusTacrolimus
45802-390TacrolimusTacrolimus
45802-700TacrolimusTacrolimus
50090-2245TacrolimusTacrolimus
51079-028TacrolimusTacrolimus
51079-817TacrolimusTacrolimus
51079-818TacrolimusTacrolimus
55111-525TacrolimusTacrolimus
55111-526TacrolimusTacrolimus
55111-527TacrolimusTacrolimus
55154-2675TacrolimusTacrolimus
55154-4395TacrolimusTacrolimus
55154-5438TacrolimusTacrolimus
60429-377TacrolimusTacrolimus
60429-378TacrolimusTacrolimus
60429-379TacrolimusTacrolimus
62175-380TacrolimusTacrolimus
62175-381TacrolimusTacrolimus
62175-382TacrolimusTacrolimus
62250-665TacrolimusTacrolimus
62250-666TacrolimusTacrolimus Capsules
62250-667TacrolimusTacrolimus Capsules
64380-720TacrolimusTacrolimus
64380-721TacrolimusTacrolimus
64380-722TacrolimusTacrolimus
68084-449TacrolimusTacrolimus
68084-450TacrolimusTacrolimus
68084-451TacrolimusTacrolimus
68462-534TacrolimusTacrolimus
69452-153TacrolimusTacrolimus
69452-154TacrolimusTacrolimus
69452-155TacrolimusTacrolimus
70518-1168TacrolimusTacrolimus
70518-2124TacrolimusTacrolimus
16729-421TacrolimusTacrolimus
16729-422TacrolimusTacrolimus
68788-7331TacrolimusTacrolimus
42291-752TacrolimusTacrolimus
42291-753TacrolimusTacrolimus Capsules
42291-754TacrolimusTacrolimus Capsules
70518-2593TacrolimusTacrolimus

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.